About the Authors

Hiroyuki Ito

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Visualization, Writing – original draft

ito@edogawa.or.jp

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Suzuko Matsumoto

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Takuma Izutsu

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Eiji Kusano

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Jiro Kondo

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Hideyuki Inoue

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Shinichi Antoku

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Tomoko Yamasaki

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Toshiko Mori

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Michiko Togane

Roles Investigation, Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Edogawa, Tokyo, Japan

Competing Interests

H Ito has received funding support and lecture fees from Taisho Pharmaceutical Co., Ltd., and lecture fees from Eli Lilly Japan KK, Boehringer Ingelheim, Takeda Pharmaceutical Company Ltd., Sanofi KK, Novo Nordisk Pharma Ltd., MSD KK, Novartis Pharma KK, Astellas Pharma, Daiichi Sankyo Company, Terumo Corporation, Mochida Pharmaceuticals, Teijin Pharma, Kissei Pharmaceuticals, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Sanwa Kagaku Kenkyusho, Dainippon Sumitomo Pharma, AstraZeneca KK, Kyowa Hakko Kirin, Shionogi and Co, Otsuka Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd., and has received consulting fee from Becton, Dickinson and Company. S Matsumoto has received lecture fees from Novo Nordisk Pharma Ltd., Astellas Pharma, and AstraZeneca KK. T Izutsu has received lecture fees from Sanofi KK, Taisho Pharmaceutical Co., Ltd., Kyowa Hakko Kirin, Bayer Yakuhin, Ltd., and Mitsubishi Tanabe Pharma Corporation. S Antoku has received lecture fees from Kyowa Hakko Kirin, Sanofi KK, Kyowa Hakko Kirin, Taisho Pharmaceutical Co., Ltd., Daiichi Sankyo Company, and Otsuka Pharmaceutical Co., Ltd. E Kusano, J Kondo, H Inoue, T Yamasaki, T Mori and M Togane have no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.